Health Condition 1: K069- Disorder of gingiva and edentulousalveolar ridge, unspecified
Conditions
Interventions
Intervention1: Dental Titanium implant: Dental titanium implants will be placed in the edentulous space of the jaw with different mucosal biotypes with connective tissue graft in thin mucosal biotype
Sponsors
Dr Laxmi Mallikarjun Boragi
INDIAN SOCIETY OF PERIODONTOLOGY
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects who are willing to participate in the study and given written consent for the same. 2. Subjects in age group of 22 years to 60 years, both males and females who are systemically healthy. 3. Completely healed edentulous ridges (at least 3 months after tooth extraction), periodontally sound neighbouring teeth, having no contraindications to the implantation procedure will be motivated for implant treatment. 4. No bone augmentation procedures before and during implant placement. 5. No medical contraindication for implant surgery. 6. Patients with no systemic diseases and bone metabolic disorders are included. 7. Patients with adequate interarch space. 8. Good oral hygiene.
Exclusion criteria
Exclusion criteria: 1. Patients with systemic diseases that could influence periodontal conditions or history of periodontitis or peri-implantitis treatment. 2. Poor oral hygiene, smoking, subjects consuming tobacco in any form, alcoholic person, use of drugs affecting bone remodeling. 3. Presence of systemic disease affecting bone loss, uncontrolled diabetes. 4. Immediate implant loading and fresh socket implant. 5. Alveolar ridges with bone defects at implantation sites. 6. General contraindications for implant surgery (e.g., Psychiatric problems, pregnant or lactating females) or presence of life-threatening conditions like cardiac complications. 7. Patient with the history of radiotherapy and chemotherapy. 8. Supraerupted opposing tooth
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Less crestal bone loss around implants placed in thin mucosal biotype with connective tissue graftTimepoint: Mucosal biotype will be assessed at baseline before implant placement and 3 months, 6 months and 9 months by transgingival probing in thin mucosal biotype post implant placement with connective tissue graft and crestal bone level will be assessed before implant placement, immediately post implant placement and 9 months using CBCT | — |
Secondary
| Measure | Time frame |
|---|---|
| More crestal bone loss around implants placed in thick mucosal biotype without connective tissue graftTimepoint: Mucosal biotype will be assessed at baseline before implant placement and 3 months, 6 months and 9 months by transgingival probing in thick mucosal biotype post implant placement without connective tissue graft and crestal bone level will be assessed before implant placement, immediately post implant placement and 9 months using CBCT | — |
Countries
India
Contacts
Public ContactDr Laxmi Mallikarjun Boragi
P.M. Nadagouda Memorial Dental College and Hospital
Outcome results
None listed